Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin-6%+1.2pp-7.2%+1.7pp-8.9%+2.1pp-11.1%+1.9pp-12.9%+2.4pp
Net margin-8%+4.1pp-12.1%+2.3pp-14.4%+1.1pp-15.5%+0.4pp-16%+0.5pp
EBITDA margin-4.7%+1.0pp-5.8%+1.6pp-7.4%+2.0pp-9.4%+1.8pp-11.3%+2.4pp
Returns
Return on assets-26.2%+9.7pp-35.9%+2.7pp-38.7%+0.2pp-38.8%-3.9pp-34.9%-1.1pp
Return on invested capital-51.8%+3.0pp-54.8%-1.8pp-53.1%-0.4pp-52.7%+1.2pp-53.9%+0.6pp
Efficiency
Asset turnover3.3×+0.3×+0.3×2.7×+0.2×2.5×+0.3×2.2×+0.1×
Liquidity
Current ratio1.5×-0.1×1.6×-0.1×1.7×+0.1×1.6×-0.2×1.8×-0.4×
Quick ratio1.2×-0.2×1.4×0.0×1.4×0.0×1.4×-0.2×1.6×-0.4×
Cash ratio0.4×-0.1×0.5×+0.1×0.4×0.0×0.5×-0.2×0.7×-0.3×
Leverage
Debt-to-assets0.6×0.0×0.6×0.0×0.6×0.0×0.6×0.0×0.6×-0.1×
Interest coverage-4.3×-1.1×-3.2×+0.7×-3.9×+0.4×-4.3×+0.4×-4.7×+3.3×
Per Share
Book value per share-$0.16+5.9%-$0.17-35.1%-$0.13-30.6%-$0.10-247%$0.07+37.4%
Valuation
Market capitalization$511.91M+133%$350.24M+7.3%$326.33M+51.1%$216M+116%$100.05M+329%
Enterprise value$586.58M+108%$420.42M+4.5%$402.33M+39.2%$288.98M+77.6%$162.74M+67.9%
Price / sales0.9×+0.4×0.7×0.0×0.7×+0.2×0.5×+0.3×0.2×+0.2×
EV / sales1.1×+0.4×0.8×0.0×0.9×+0.2×0.7×+0.3×0.4×+0.2×
Earnings yield-8.5%+20.8pp-17.3%+3.0pp-20.3%+10.2pp-30.5%+33.8pp-64.3%+213pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do The Oncology Institute, Inc.'s ratios come from?
Every ratio is computed from The Oncology Institute, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.